Mark Your Calendar: Clinical Fertility Day for the Public on 11/18/2018
A rare opportunity for fertility patients to learn about the cutting-edge treatment options directly from global experts in NYC
Sunday, November 18, 2018 2:00 PM – 6:00 PM New York Marriott East Side 525 Lexington Avenue (at 49th Street) New York, NY 10017
We expect the space to sell out. Reserve your seat here!
Learn about the most promising fertility treatments directly from some of the leading fertility experts in the world in an immersive, interactive afternoon in New York City! The Foundation for Reproductive Medicine presents Clinical Fertility Day for the Public on Sunday, November 18, 2018, as a part of the third Translational Reproductive Biology and Clinical Reproductive Endocrinology conference, a popular professional meeting for reproductive biologists, reproductive endocrinology physicians and others working in adjacent field.
Open to the public for an affordable registration fee of $75.00, Clinical Fertility Day is designed to encourage fertility patients to learn about the evolving scientific understanding of various infertility issues, as well as the latest developments in fertility treatments, directly from the leading experts in the world. This is a truly unique opportunity to interact with the sought-after speakers and gain invaluable knowledge about some of the most complex infertility issues and potential treatment options!
Topics include IVF, endometriosis, PCOS, male infertility, fertility preservation and more.
Registration is now open! Registration can be made on the Foundation for Reproductive Medicine's website.
|2:00 – 2:20||**Session 1** Fertility preservation: When should a woman worry about her future fertility, and what are then her options? **Vitaly A. Kushnir**, _MD_|
|2:20 – 2:40||**Session 2** Is IVF the best first treatment for all infertility? **Pasquale Patrizio**, _MD, MS_|
|2:40 – 3:00||**Session 3** Is there evidence-based treatment for implantation failure? **Neeta Singh**, _MD_|
|3:00 – 3:30||**Session 4 **Is there clinical value in testing embryos for chromosomal abnormalities before transfer? **Norbert Gleicher**, _MD_|
|3:20 – 3:40||**Session 5** Highly Individualized Egg Retrieval (HIER) in older women and younger women with premature ovarian aging **David H. Barad**,_ MD, MS _|
|3:40 – 4:00||_Coffee Break_|
|4:00 – 4:20||**Session 6** Endometriosis, an anatomical, endocrinological and immunological condition **Norbert Gleicher**, _MD_|
|4:20 – 4:40||**Session 7** Repeated pregnancy loss **Andrea Weghofer**, _MD, PhD, MS, MBA_|
|4:40 – 5:00||**Session 8** _Precision ovarian preparation for customized IVF **John Zhang**, MD, MSc, PhD_|
|5:00 – 5:20||**Session 9 **Is there male fertility treatment beyond ICSI? **Sherman J. Silber**, _MD_|
|5:20 – 6:00||**Session 10** An expert panel answers questions **David H. Barad, **_MD, MS_** Norbert Gleicher**, _MD_ **Pasquale Patrizio**, _MD, MS_ **Sherman J. Silber**, _MD_ **Neeta Singh**, _MD_ **Andrea Weghofer**, _MD, PhD, MS, MBA_ **John Zhang**, _MD, MSc, PhD_|
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- A positive COVID-19 update, as things are quickly getting betterNew York City and a big part of the country are quickly coming back to almost normal, as case numbers, hospitalizations and deaths from COVID-19 are quickly dropping. There is still some fear mongering going on, especially when it comes to the so-called new strains of the virus, which are now dominating. The good news, however, is the newest research data suggest that the immunity obtained from Pfeizer and Moderna vaccines are also protective against the new strains. That does not mean that the SARS-CoV-2 virus may not at some point mutate in a way that allows it to escape the antibody response created by those vaccines; but even if that were to be the case, as we now know through research on this virus, our cellular immune system also has long-term memory that can be effective in preventing infection and especially in keeping the severity of any infection limited.
- The latest news in Science: May 2021In this section we attempt to draw attention to science papers we perceive as potentially important for the basic understanding of reproductive biology and, therefore, may have translational relevance to infertility practice at some future point.
- Ethical concern with contemporary IVF practiceMillions of people who until only a few decades ago had no chance of genetic parenthood, now have children of their own. Even for professionals in the field, the progress achieved in the understanding of basic physiological processes relating to female and male infertility and basic human embryology over the last few decades, at times, appear futuristic.
- COVID-19 Bulletin, July 6, 2020News you, likely, will not find in the media [This article deals with a constantly evolving situation. It was written